These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 8399644

  • 1. Low- and high-turnover bone disease in continuous ambulatory peritoneal dialysis: effects of low-Ca2+ peritoneal dialysis solution.
    Carozzi S, Nasini MG, Santoni O, Pietrucci A.
    Perit Dial Int; 1993; 13 Suppl 2():S473-5. PubMed ID: 8399644
    [Abstract] [Full Text] [Related]

  • 2. Low calcium peritoneal dialysis solution. Effects on calcium metabolism and bone disease in CAPD patients.
    Carozzi S, Nasini MG, Schelotto C, Caviglia PM, Santoni O, Pietrucci A.
    ASAIO J; 1992; 38(3):M593-5. PubMed ID: 1457929
    [Abstract] [Full Text] [Related]

  • 3. Long-term dialysis with low-calcium solution (1.0 mmol/L) in CAPD: effects on bone mineral metabolism. Collaborators of the Multicenter Study Group.
    Weinreich T, Ritz E, Passlick-Deetjen J.
    Perit Dial Int; 1996; 16(3):260-8. PubMed ID: 8761540
    [Abstract] [Full Text] [Related]

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 5. Low dialysate calcium in continuous ambulatory peritoneal dialysis: a randomized controlled multicenter trial. The Peritoneal Dialysis Multicenter Study Group.
    Weinreich T, Passlick-Deetjen J, Ritz E.
    Am J Kidney Dis; 1995 Mar; 25(3):452-60. PubMed ID: 7872324
    [Abstract] [Full Text] [Related]

  • 6. Effect of CAPD and hemodialysis on parathyroid function.
    Malberti F, Corradi B, Imbasciati E.
    Adv Perit Dial; 1996 Mar; 12():239-44. PubMed ID: 8865912
    [Abstract] [Full Text] [Related]

  • 7. Long-term effects of intermittent oral alphacalcidol, calcium carbonate and low-calcium dialysis (1.25 mmol L-1) on secondary hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis.
    Brandi L, Nielsen PK, Bro S, Daugaard H, Olgaard K.
    J Intern Med; 1998 Aug; 244(2):121-31. PubMed ID: 10095798
    [Abstract] [Full Text] [Related]

  • 8. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V, Torregrosa V.
    Nefrologia; 2008 Aug; 28 Suppl 3():67-78. PubMed ID: 19018742
    [Abstract] [Full Text] [Related]

  • 9. Low calcium (1.25 mmol/L) dialysate can normalize relative hypoparathyroidism in CAPD patients with low bone turnover.
    Shigematsu T, Kawaguchi Y, Kubo H, Nakayama M, Kato N, Yamamoto H, Osaka N, Hayakawa H, Ogawa A, Sakai O.
    Adv Perit Dial; 1996 Aug; 12():250-6. PubMed ID: 8865914
    [Abstract] [Full Text] [Related]

  • 10. Low-calcium dialysis fluid and oral calcium carbonate in CAPD. A method of controlling hyperphosphataemia whilst minimizing aluminium exposure and hypercalcaemia.
    Hutchison AJ, Freemont AJ, Boulton HF, Gokal R.
    Nephrol Dial Transplant; 1992 Aug; 7(12):1219-25. PubMed ID: 1337163
    [Abstract] [Full Text] [Related]

  • 11. Low calcium dialysate and hyperparathyroidism.
    Duncan R, Cochrane T, Bhalla C, Michael J, Richards NT, Adu D.
    Perit Dial Int; 1996 Aug; 16 Suppl 1():S499-502. PubMed ID: 8728256
    [Abstract] [Full Text] [Related]

  • 12. Long-term effects of intravenous 1 alpha (OH)D3 combined with CaCO3 and low-calcium dialysis on secondary hyperparathyroidism and biochemical bone markers in patients on chronic hemodialysis.
    Brandi L, Daugaard H, Nielsen PK, Jensen LT, Egsmose C, Olgaard K.
    Nephron; 1996 Aug; 74(1):89-103. PubMed ID: 8883025
    [Abstract] [Full Text] [Related]

  • 13. Renal osteodystrophy in dialysis patients: diagnosis and treatment.
    Fournier A, Oprisiu R, Hottelart C, Yverneau PH, Ghazali A, Atik A, Hedri H, Said S, Sechet A, Rasolombololona M, Abighanem O, Sarraj A, El Esper N, Moriniere P, Boudailliez B, Westeel PF, Achard JM, Pruna A.
    Artif Organs; 1998 Jul; 22(7):530-57. PubMed ID: 9684690
    [Abstract] [Full Text] [Related]

  • 14. Differences in corrective mode for divalent ions and parathyroid hormone between standard- and low-calcium dialysate in patients on continuous ambulatory peritoneal dialysis--result of a nationwide survey in Japan.
    Yamamoto H, Kasai K, Hamada C, Hasegawa H, Higuchi C, Hiramatsu M, Hosoya T, Itami N, Kawanishi H, Kubota M, Masakane I, Minakuchi J, Mitarai T, Nakao T, Suzuki H, Tomo T, Kawaguchi Y, Japan Peritoneal Dialysis-Mineral Bone Disorders (PD-MBD) Research Group.
    Perit Dial Int; 2008 Jun; 28 Suppl 3():S128-30. PubMed ID: 18552242
    [Abstract] [Full Text] [Related]

  • 15. A randomized trial comparing 1.25 mmol/l calcium dialysate to 1.75 mmol/l calcium dialysate in CAPD patients.
    Johnson DW, Rigby RJ, McIntyre HD, Brown A, Freeman J.
    Nephrol Dial Transplant; 1996 Jan; 11(1):88-93. PubMed ID: 8649658
    [Abstract] [Full Text] [Related]

  • 16. The requirement of low calcium dialysate in patients on continuous ambulatory peritoneal dialysis receiving calcium carbonate as a phosphate binder.
    Cheng IK, Lu HB, Chan CY, Cheng SW, Robinson JD, Tam SC, Lo WK, Cheung WC.
    Clin Nephrol; 1993 Aug; 40(2):100-5. PubMed ID: 8222365
    [Abstract] [Full Text] [Related]

  • 17. High-normal calcium (1.35 mmol/l) dialysate in patients on CAPD: efficient and safe long-term control of plasma calcium, phosphate, and parathyroid hormone.
    Bro S, Brandi L, Olgaard K.
    Nephrol Dial Transplant; 1996 Aug; 11(8):1586-91. PubMed ID: 8856216
    [Abstract] [Full Text] [Related]

  • 18. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate.
    Cho MS, Lee KS, Lee YK, Ma SK, Ko JH, Kim SW, Kim NH, Choi KC.
    Korean J Intern Med; 2002 Jun; 17(2):114-21. PubMed ID: 12164088
    [Abstract] [Full Text] [Related]

  • 19. Short-term effects of low-calcium dialysis solutions on calcium mass transfer, ionized calcium, and parathyroid hormone in CAPD patients.
    Pagliari B, Baretta A, De Cristofaro V, Samà F, Cantaluppi A, Martis L, Imbasciati E.
    Perit Dial Int; 1991 Jun; 11(4):326-9. PubMed ID: 1751598
    [Abstract] [Full Text] [Related]

  • 20. Low Ca2+ dialysate. Effects on bone metabolism in the course of paired filtration dialysis.
    Carozzi S, Nasini MG, Pietrucci A, Costa M, Mantero R.
    ASAIO J; 1994 Jun; 40(3):M683-5. PubMed ID: 8555601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.